202 related articles for article (PubMed ID: 23615499)
1. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
[TBL] [Abstract][Full Text] [Related]
2. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS).
Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M;
Am J Respir Crit Care Med; 2024 May; 209(9):1141-1151. PubMed ID: 38346237
[No Abstract] [Full Text] [Related]
3. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
Tang W; Bose B; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW
Clin J Am Soc Nephrol; 2013 May; 8(5):773-80. PubMed ID: 23349331
[TBL] [Abstract][Full Text] [Related]
4. Key considerations for modelling the long-term costs and benefits of treatments for ANCA-associated vasculitis.
Berdunov V; Ramirez de Arellano A; Li T; Vintderdag H; Baxter G
Clin Exp Rheumatol; 2024 Apr; 42(4):782-785. PubMed ID: 38526008
[TBL] [Abstract][Full Text] [Related]
5. ANCA-associated vasculitis after COVID-19.
Izci Duran T; Turkmen E; Dilek M; Sayarlioglu H; Arik N
Rheumatol Int; 2021 Aug; 41(8):1523-1529. PubMed ID: 34100115
[TBL] [Abstract][Full Text] [Related]
6. Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides.
Hakroush S; Korsten P; Ströbel P; Tampe B
Front Immunol; 2024; 15():1340999. PubMed ID: 38380320
[TBL] [Abstract][Full Text] [Related]
7. Risk of Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids.
Junek ML; Merkel PA; Vilayur E; Wald R; Khalidi N; Jayne D; Walsh M;
Arthritis Rheumatol; 2024 Mar; ():. PubMed ID: 38485450
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive treatment of membranoproliferative glomerulonephritis.
Faedda R; Satta A; Tanda F; Pirisi M; Bartoli E
Nephron; 1994; 67(1):59-65. PubMed ID: 8052369
[TBL] [Abstract][Full Text] [Related]
9. Rational therapy in systemic necrotising vasculitis.
Carruthers DM
Clin Med (Lond); 2001; 1(1):7-9. PubMed ID: 11358081
[No Abstract] [Full Text] [Related]
10. Plasma exchange therapy for acute necrotizing encephalopathy of childhood.
Li K; Zhang T; Liu G; Jin P; Wang Y; Wang L; Xu M; Liu C; Liu Y; Zhou T; Xu Y; Yang Y; Fang B; Yang X; Liu C; Qian S
Pediatr Investig; 2021 Jun; 5(2):99-105. PubMed ID: 34179705
[TBL] [Abstract][Full Text] [Related]
11. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
[TBL] [Abstract][Full Text] [Related]
12. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
13. Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.
Jayne DRW; Bruchfeld AN; Harper L; Schaier M; Venning MC; Hamilton P; Burst V; Grundmann F; Jadoul M; Szombati I; Tesař V; Segelmark M; Potarca A; Schall TJ; Bekker P;
J Am Soc Nephrol; 2017 Sep; 28(9):2756-2767. PubMed ID: 28400446
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Viviano L; Tchao NK; Phippard DJ; Asare AL; Lim N; Ikle D; Jepson B; Brunetta P; Allen NB; Fervenza FC; Geetha D; Keogh K; Kissin EY; Monach PA; Peikert T; Stegeman C; Ytterberg SR; Mueller M; Sejismundo LP; Mieras K; Stone JH;
N Engl J Med; 2013 Aug; 369(5):417-27. PubMed ID: 23902481
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis--a 25-year perspective.
Szpirt WM
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i146-9. PubMed ID: 25770166
[TBL] [Abstract][Full Text] [Related]
16. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.
Karras A; Pagnoux C; Haubitz M; Groot K; Puechal X; Tervaert JWC; Segelmark M; Guillevin L; Jayne D;
Ann Rheum Dis; 2017 Oct; 76(10):1662-1668. PubMed ID: 28546260
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis.
Jones RB
Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382
[TBL] [Abstract][Full Text] [Related]
19. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis.
Beck L; Bomback AS; Choi MJ; Holzman LB; Langford C; Mariani LH; Somers MJ; Trachtman H; Waldman M
Am J Kidney Dis; 2013 Sep; 62(3):403-41. PubMed ID: 23871408
[TBL] [Abstract][Full Text] [Related]
20. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
Geetha D; Specks U; Stone JH; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Tchao NK; Ikle D; Jepson B; Brunetta P; Fervenza FC;
J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
